Page 13 - hypertension_newsletter5_draft2
P. 13
REFLECTIONS
Hypertension
Hypertension Global Newsletter #5 2023
ACRONYMS:
Acronyms: ACEi, angiotensin-converting enzyme inhibitor; AML, amlodipine; AMLO, amlodipine; ARB, angiotensin receptor blocker;
ARNI, angiotensin receptor/neprilysin inhibitor; ASCVD, atherosclerotic cardiovascular disease; BB, beta blocker; BP, blood pressure;
Hypertension
CAD, coronary artery disease; CAN, candesartan; CCB, calcium channel blocker; CI, confidence interval; CV, cardiovascular; DBP,
diastolic blood pressure; eGFR, estimated glomerular filtration rate; ESC, European Society of Cardiology; ESH, European Society
of Hypertension; HCTZ, hydrochlorothiazide; HF, heart failure; HFrEF, heart failure with reduced ejection fraction; HR, hazard ratio;
HYVET, Hypertension in the Very Elderly Trial; ISH, International Society of Hypertension; MCS, multisource comorbidity score; MPC,
multi-pill combination; MI, myocardial infarction; PDC, prescription days covered; RAM, ramipril; RAMI, ramipril; RCTs, randomised
controlled trials; RR, risk ratio; SBP, systolic blood pressure; SDOH, social determinants of health; SPCs, single-pill combination; T/
TL, thiazide/thiazide-like; TIA, transient ischemic attack; TTR, time in target range; VAL, valsartan.
TABLE OF CONTENTS
